Journal article

Epidemiology of Treated Epilepsy in New Zealand Children: A Focus on Ethnicity

S Ali, J Stanley, S Davis, N Keenan, IE Scheffer, LG Sadleir

Neurology | Published : 2021

Abstract

Background and ObjectivesTo determine the period prevalence and incidence of treated epilepsy in a New Zealand pediatric cohort with a focus on ethnicity and socioeconomic status.MethodsThis was a retrospective cohort study. The New Zealand Pharmaceutical Collection database was searched for individuals ≤18 years of age dispensed an antiseizure medication ASM in 2015 from areas capturing 48% of the New Zealand pediatric population. Medical records of identified cases were reviewed to ascertain the indication for the ASM prescription. Population data were derived from the New Zealand 2013 Census.ResultsA total of 3,557 ASMs were prescribed during 2015 in 2,594 children, of whom 1,717 66% chil..

View full abstract

University of Melbourne Researchers

Grants

Awarded by National Institutes of Health


Funding Acknowledgements

The authors thank the Ministry of Health, New Zealand, for conducting the search and supplying the information from the Pharmaceutical Collection database and Statistics New Zealand for providing regional population data. S. Ali thanks Freemasons New Zealand for their financial support.